Journals / MN Kardiyoloji / 2022 / Cilt: 29 - Sayı: 2

Acute Myocardial Infarction in Pheochromocytoma Patients: Obstructive-Nonobstructive Dilemma

Feokromasitoma Hastasında Akut Miyokard Enfarktüsü: Obstrüktif-Nonobstrüktif İkilemi

Pages
105–108
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, the approach and treatment of a patient with a history of pheochromocytoma and presenting with acute coronary syndrome is discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pheochromocytomas are rare neuroendocrine tumors that originate from chromaffin tissue and cause clinical effects by secreting catechola‐ mines.
📊
Key Findings & Data:Also ca‐ techolamines significantly increase the risk of cardiovascular disease and mortality due to various cardiac pathophysiological effects of them.
💡
Conclusion & Impact:In this case report, the approach and treatment of a patient with a history of pheochromocytoma and presenting with acute coronary syndrome is discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pheochromocytomas are rare neuroendocrine tumors that originate from chromaffin tissue and cause clinical effects by secreting catechola‐ mines. Depending on the broad spectrum of action of catecholamines, they can mimic many diseases such as myocardial infarction. Also ca‐ techolamines significantly increase the risk of cardiovascular disease and mortality due to various cardiac pathophysiological effects of them. When a patient with pheochromocytoma presents with acute coronary syndrome, both the diagnosis of stress cardiomyopathy mimicking myo‐ cardial infarction and true myocardial infarction, are possible and may cause confusion in the diagnostic algorithm, and because of its more frequent occurrence, stress cardiomyopathy may be considered and approached less urgently. In this case report, the approach and treatment of a patient with a history of pheochromocytoma and presenting with acute coronary syndrome is discussed.

Özet

Feokromasitomalar, kromaffin dokudan köken alan, katekolamin salgılayarak klinik etkilerini oluşturan ve nadir görülen nöroendokrin tümörlerdir. Katekolaminlerin geniş etki spektrumuna bağlı olarak miyokard enfarktüsü gibi çok fazla hastalığı taklit edebildikleri gibi, yine katekolaminlerin çeşitli kardiyak patofizyolojik etkileri nedeni ile kardiyovasküler hastalık riskini ve mortaliteyi önemli oranda arttırırlar. Feokromasitomalı bir hasta akut koroner sendrom tablosunda başvurduğunda, miyokard enfarktüsünü taklit eden stres kardiyomiyopatisi ve gerçek miyokard enfarktüsü tanılarından ikisi de olasıdır ve tanı algoritmasında kafa karışıklığı yaratabilir ve bazen daha sık görülmesi nedeni ile stres kardiyomiyopatisi düşünülerek hastaya daha az ivedi yaklaşılabilir. Bu olgu sunumu ile feokromasit‐ o ma öyküsü olan ve akut koroner sendrom tablosunda başvuran bir hastaya yaklaşım ve tedavi tartışılmıştır.

🔖

Cite This Article

ÖZTÜRK, C., ÇAKIR, B., ALTAY, S. (2022). Acute Myocardial Infarction in Pheochromocytoma Patients: Obstructive-Nonobstructive Dilemma. MN Kardiyoloji, Cilt: 29 - Sayı: 2, 105–108. https://ajindex.com/articles/581454

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Lenders JW. Eisenhofer G. Mannelli M. Pacak K. Phaeo ­ chro mocytoma. Lancet. 2005;366(9486):665­75
  2. Reisch N. Peczkowska M. Januszewicz A. Neumann HPH. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens. 2006;24(12):2331­9
  3. Chen F. Zheng M. Li X. Peng Y. Chen M. ST­Segment Elevation Myocardial Infarction Related to Potential Spontaneous Coronary Thrombosis in Pheochromocytoma Crisis. Front Endocrinol (Lausanne). 2020;11:140
  4. Stein PP. and Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution’s experience. Medicine (Baltimore). 1991;70(1):46­66
  5. Galetta F. Franzoni F. Bernini G. et al. Cardiovascular complications in patients with pheochromocytoma: a mini­review. Biomed Pharmacother. 2010;64(7):505­9
  6. Neumann HPH. Young Jr WF. Eng C. Pheochromocytoma and paraganglioma. N Eng J Med. 2019;381(6):552­65
  7. Weingarten TN. Welch TL. Moore TL. et al. Preoperative levels of catecholamines and metanephrines and intraope rative hemodynamics of patients undergoing pheo chro­ mocytoma and paraganglioma resection. Urology. 2017; 100:131­8
  8. Adameova A. Abdellatif Y. Dhalla NS. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress­induced heart disease. Can J Physiol Pharmacol. 2009;87(7):493­514. 9. van Zaane B. Stuijver DJ. Squizzato A. Gerdes VE. Arterial and venous thrombosis in endocrine diseases. Semin Thromb Hemost. 2013;39(5):489­95
  9. Yukihito H. Sasaki S. Nakagawa K. et al. Excess norepinephrine impairs both endothelium­dependent and­independent vasodilation in patients with pheochromocytoma. Hypertension. 2002;39(2):513­8.